Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Epigenetic Profiling Could Refine Prognosis in Acute Myeloid Leukemia

By LabMedica International staff writers
Posted on 10 Jul 2026

Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with heterogeneous biology that complicates prognostication and treatment selection. More...

Genetic testing clarifies many drivers, yet it often fails to explain divergent disease trajectories among patients. Understanding non-genetic mechanisms of gene regulation has become an important diagnostic frontier. A new study shows how epigenetic mapping can stratify AML into biologically meaningful groups.

Karolinska Institutet, in collaboration with Kyoto University, evaluated an epigenetic mapping approach that profiles how accessible DNA is within the cell nucleus to infer which genes may be active. The method captures chromatin accessibility, enabling classification based on gene regulatory states rather than DNA sequence changes. Researchers assessed regulatory patterns to delineate molecular programs that underlie AML heterogeneity and clinical behavior.

The investigation analyzed samples from 1,563 patients in Sweden and Japan. Using measurements of DNA accessibility, the team divided AML into 16 groups with distinct molecular and biological characteristics. The study integrated multiple data types, including gene expression, DNA methylation, and single-cell analyses, to define each group’s patterns of gene regulation, cell differentiation, and disease progression.

Several epigenetically defined groups were more closely associated with patient survival than existing classification systems, indicating added prognostic value. Drug-response profiling across 250 agents revealed group-specific differences in sensitivity that aligned with the epigenetic categories. The authors noted that these findings, published in Nature on July 8, 2026, do not replace current genetics-based systems but can complement them, and that additional studies are needed to validate the results and clarify clinical use.

“Our results show that, based on epigenetic analyses, leukemia can be divided into new biologically relevant subgroups that provide more information than genetic analyses alone,” said Sören Lehmann, professor at the Department of Medicine, Huddinge, Karolinska Institutet.

Related Links
Karolinska Institutet
Kyoto University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.